Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 104,554 | 83,529 | 38,791 | 51,442 | 41,698 |
| Operating Income | -104,554 | -83,529 | -38,791 | -51,442 | -41,698 |
| Other Income | 15,530 | 11,945 | 1,129 | 58 | 338 |
| Pre-tax Income | -89,024 | -71,584 | -37,662 | -51,384 | -41,360 |
| Net Income Continuous | -89,024 | -71,584 | -37,662 | -51,384 | -41,360 |
| Net Income | $-89,024 | $-71,584 | $-37,662 | $-51,384 | $-41,360 |
| EPS Basic Total Ops | -1.89 | -2.01 | -12.05 | -9.48 | -14.12 |
| EPS Basic Continuous Ops | -1.89 | -2.01 | -12.05 | -9.49 | -11.88 |
| EPS Diluted Total Ops | -1.89 | -2.01 | -12.05 | -9.48 | -14.12 |
| EPS Diluted Continuous Ops | -1.89 | -2.01 | -12.05 | -9.49 | -11.88 |
| EPS Diluted Before Non-Recurring Items | -1.89 | -2.01 | 0.24 | -9.48 | -14.12 |
| EBITDA(a) | $-103,813 | $-87,835 | $-38,576 | $-51,188 | $-41,479 |